Odyssey Health, Inc.

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 68% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Odyssey Health, Inc.'s trades of Oragenics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
278.61
Quantity 78,382 -35.9%
Value US$536,213
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
398.95
Quantity 96,859 +5.0%
Value US$4,190,030
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
233.54
Quantity 38,927 +13.8%
Value US$2,545,650
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
4.27
Quantity 5,000 -29.3%
Value US$21,350
US Oragenics Inc (OGEN)
Transaction date
Proposed sale
Price
4.69
Quantity 17,044
Value US$79,936
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-18 2025-06-18
US Oragenics Inc (OGEN)
S Sale
78,382 -35.9%
278.61
US$536,213 		78,382 -35.9% 278.61 US$536,213
2025-06-18 2025-06-17
US Oragenics Inc (OGEN)
S Sale
96,859 +5.0%
398.95
US$4,190,030 		96,859 +5.0% 398.95 US$4,190,030
2025-06-16 2025-06-16
US Oragenics Inc (OGEN)
S Sale
38,927 +13.8%
233.54
US$2,545,650 		38,927 +13.8% 233.54 US$2,545,650
2025-06-16 2025-06-13
US Oragenics Inc (OGEN)
S Sale
5,000 -29.3%
4.27
US$21,350 		5,000 -29.3% 4.27 US$21,350
2025-06-13 2025-06-10
US Oragenics Inc (OGEN)
PrS Proposed sale
17,044
4.69
US$79,936 		17,044 4.69 US$79,936